Immune Checkpoint Receptors in AML-Leukemic Initiating Cells

NCT03449745 · clinicaltrials.gov ↗
COMPLETED
Status
199
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

University Hospital, Bordeaux